Trevor J. Powles — Endo Lab

article 1990

Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer

·doi:10.1016/0277-5379(90)90162-m

Seventy-four post-menopausal women with metastatic breast cancer were treated with a combination hormonal regimen consisting of tamoxifen, aminoglutethimide danazol and medroxyprogesterone acetate (POND). 72% of the patients had received no…

article 1983

246 Treatment of disseminated breast cancer with multiple hormone therapy using tamoxifen, danazol, aminoglutethimide and hydrocortisone

·doi:10.1016/0022-4731(83)91746-6

article 1982

Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone.

Multiple-endocrine therapy with combinations of various types of treatment has not been evaluated properly in spite of the success of individual types of hormone treatment. This paper reports the early results of a randomized controlled cli…